TRCT
APLM icon

Tower Research Capital (TRC)’s Apollomics APLM Stock Holding History

Tower Research Capital (TRC)’s Portfolio APLM Stock Details APLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-37
Closed -$361 – 5166
2024
Q4 		$361 Buy
+37
New +$429 ﹤0.01% 5305
2024
Q1 		– Hold
0
– -$13 – 5837
2023
Q4 		– Hold
0
– – – 5832
2023
Q2 		– Sell
-2
Closed -$4K – 6025
2023
Q1 		$4K Buy
+2
New +$5.36K ﹤0.01% 5038

Other funds holding APLM

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tower Research Capital (TRC)'s APLM Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Apollomics (APLM) in Q1 2025, closing a stake of 37 shares — an estimated $361 sold.

Tower Research Capital (TRC) first reported a position in APLM in Q1 2023 and held it in 2 quarters. The position peaked at $4K in Q1 2023. 4 funds tracked by Wall St. Rank hold APLM as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Apollomics position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 37 Apollomics shares in Q1 2025, an estimated $361.
  • Tower Research Capital (TRC) first reported a position in Apollomics in Q1 2023 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Apollomics position peaked at $4K in Q1 2023.
  • 4 funds tracked by Wall St. Rank held Apollomics as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.